# Choroideremia Gene Therapy Clinical Trial

> **NCT02553135** · PHASE2 · COMPLETED · sponsor: **Byron Lam** · enrollment: 6 (actual)

## Conditions studied

- Choroideremia

## Interventions

- **BIOLOGICAL:** Injection of AAV2-REP1 (10e11 vg)

## Key facts

- **NCT ID:** NCT02553135
- **Lead sponsor:** Byron Lam
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553135, "Choroideremia Gene Therapy Clinical Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02553135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*